New Treatment for Chronic Migraine Sufferers by Hannah Joy on May 6, 2021 at 4:29 PM
About 14% of the world population is suffering from migraine
The new migraine therapy helps restore microtubule or the neuronal plasticity
New way to treat chronic migraine has been discovered by researchers, where a new cellular mechanism helps prevent migraines by restoring neuronal plasticity.
Amynah Pradhan, associate professor of psychiatry at the University of Illinois Chicago, is the senior author of the study, whose goal was to identify a new mechanism of chronic migraine, and propose a cellular pathway for migraine therapies.
New Treatment for Chronic Migraine Sufferers
New Drug for Migraine Approved by Colleen Fleiss on February 25, 2021 at 8:03 AM
The US Food & Drug Administration (US FDA) has approved Granules Abbreviated New Drug Application (ANDA) for acetaminophen, aspirin, and caffeine tablets, indicated for the treatment of migraine.
It is bioequivalent to the Reference Listed Drug (RLD) product, Excedrin Migraine tablets, 250 mg/250 mg/65 mg, of GlaxoSmithKline Consumer Healthcare.
The product would be manufactured at Granules India s Hyderabad facility and is expected to be launched shortly.
‘Granules Abbreviated New Drug Application (ANDA) for acetaminophen, aspirin, and caffeine tablets, indicated for migraine treatment has been approved by USFDA. ’ We are pleased to announce approval of Acetaminophen, Aspirin and Caffeine tablets, emphasising our focus on building a sustainable OTC product portfolio in the US market. We received approval for this triple combination product within 14 months from fi